Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NAMS NewAmsterdam Pharma > Detailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
12.750
+0.120+0.95%
Close  02/03 16:00 ET
12.7500.0000.00%
Post Mkt Price 02/03 16:37 ET
High
12.840
Open
12.500
Turnover
317.57K
Low
12.500
Pre Close
12.630
Volume
25.28K
Market Cap
1.04B
P/E(TTM)
Loss
52wk High
32.880
Shares
81.56M
P/E(Static)
Loss
52wk Low
7.520
Float Cap
397.62M
Bid/Ask %
-77.78%
Historical High
32.880
Shs Float
31.19M
Volume Ratio
0.16
Historical Low
7.520
Dividend TTM
--
Div Yield TTM
--
P/B
1.83
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.08%
Amplitude
2.69%
Avg Price
12.563
Lot Size
1
Float Cap
397.62M
Bid/Ask %
-77.78%
Historical High
32.880
Shs Float
31.19M
Volume Ratio
0.16
Historical Low
7.520
Dividend TTM
--
P/B
1.83
Dividend LFY
--
Turnover Ratio
0.08%
Amplitude
2.69%
Avg Price
12.563
Lot Size
1
Price Forecast

News

Comment

Company Overview More
NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.
CEO: Dr. Michael Harvey Davidson, M.D.
Market: NASDAQ
Listing Date: 12/09/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist